SAN FRANCISCO, April 28, 2014 (GLOBE NEWSWIRE) -- The Life Sciences Foundation, a nonprofit organization dedicated to capturing the history, preserving the heritage and sharing the stories of biotechnology, appoints Chris Garabedian to its board of advisors.
Since 2011, Chris Garabedian has been president and CEO of Sarepta Therapeutics in Cambridge, MA. Earlier in his career, he served as vice president of corporate strategy for Celgene Corporation, in global leadership roles spanning corporate development, marketing and medical affairs at Gilead Sciences, and as an independent consultant to early-stage biopharmaceutical companies.
"Chris is a valuable addition to the board given his perspective on the evolution of the industry over the past 20 years," says Heather Erickson, President and CEO of the Life Sciences Foundation.
Chris Garabedian remarked, "I'm pleased to join the Life Sciences Foundation, an organization with an important mission to document and celebrate the biotechnology industry's rich scientific heritage and significant contributions to improving human health."
The Life Sciences Foundation educates and inspires curious minds with the history and continuing significance of biotechnology. The Foundation is collecting, preserving and sharing firsthand information about the people, organizations and discoveries that define biotechnology and continue to shape the world in which we live.
More information is available at biotechhistory.org.